fashion -WSS

fashion

author：comprehensive 2025-10-06 15:02:11 - browse：77863

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Study: Spinal cord stimulation helps patients with paralysis walk again

WSS

As obesity drug market grows, telehealth companies court payers

Kellogg’s is going to war over Mexico’s nutrition label rules

Hospitals struggle to profit from CAR

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Affordable Connectivity Program vital to health care, experts say

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

knowledge

fashion

hotspot

Cancer drug shortages should be causing more outrage

Can U.S. cancer drug shortages be fixed?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Can U.S. cancer drug shortages be fixed?

Guidelines to prevent youth baseball injuries need more muscle

Study identifies new proteins linked to dementia risk 25 years later

Tori Bowie and the unacceptable rates of Black maternal death

Trans patients at the end of life deserve respect and dignity

knowledge

FDA greenlights medical device to combat bladder issues

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Winning ticket for $1 billion Powerball jackpot sold in California

Driven by the pandemic, applicants flood public health schools

Indian pharmaceutical industry in denial over drug

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Wikipedia

focus

hotspot

hotspot